These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 23827191

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance.
    Loessner D, Quent VM, Kraemer J, Weber EC, Hutmacher DW, Magdolen V, Clements JA.
    Gynecol Oncol; 2012 Dec; 127(3):569-78. PubMed ID: 22964375
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment.
    Dong Y, Stephens C, Walpole C, Swedberg JE, Boyle GM, Parsons PG, McGuckin MA, Harris JM, Clements JA.
    PLoS One; 2013 Dec; 8(2):e57056. PubMed ID: 23451143
    [Abstract] [Full Text] [Related]

  • 4. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells.
    Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC.
    Biomaterials; 2010 Nov; 31(32):8494-506. PubMed ID: 20709389
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Laminin-1-derived scrambled peptide AG73T disaggregates laminin-1-induced ovarian cancer cell spheroids and improves the efficacy of cisplatin.
    Yoshida Y, Kurokawa T, Nishikawa Y, Orisa M, Kleinman HK, Kotsuji F.
    Int J Oncol; 2008 Mar; 32(3):673-81. PubMed ID: 18292945
    [Abstract] [Full Text] [Related]

  • 7. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab.
    Pickl M, Ries CH.
    Oncogene; 2009 Jan 22; 28(3):461-8. PubMed ID: 18978815
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.
    Prezas P, Arlt MJ, Viktorov P, Soosaipillai A, Holzscheiter L, Schmitt M, Talieri M, Diamandis EP, Krüger A, Magdolen V.
    Biol Chem; 2006 Jun 22; 387(6):807-11. PubMed ID: 16800744
    [Abstract] [Full Text] [Related]

  • 10. Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma.
    Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG, Clements JA.
    Cancer Res; 2010 Apr 01; 70(7):2624-33. PubMed ID: 20332224
    [Abstract] [Full Text] [Related]

  • 11. Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
    Hossein G, Halvaei S, Heidarian Y, Dehghani-Ghobadi Z, Hassani M, Hosseini H, Naderi N, Sheikh Hassani S.
    Cancer Med; 2019 Aug 01; 8(9):4315-4329. PubMed ID: 31197964
    [Abstract] [Full Text] [Related]

  • 12. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y, Kaushal A, Bui L, Chu S, Fuller PJ, Nicklin J, Samaratunga H, Clements JA.
    Clin Cancer Res; 2001 Aug 01; 7(8):2363-71. PubMed ID: 11489814
    [Abstract] [Full Text] [Related]

  • 13. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.
    Shahinian H, Loessner D, Biniossek ML, Kizhakkedathu JN, Clements JA, Magdolen V, Schilling O.
    Mol Oncol; 2014 Feb 01; 8(1):68-82. PubMed ID: 24120346
    [Abstract] [Full Text] [Related]

  • 14. The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway.
    Ogishima J, Taguchi A, Kawata A, Kawana K, Yoshida M, Yoshimatsu Y, Sato M, Nakamura H, Kawata Y, Nishijima A, Fujimoto A, Tomio K, Adachi K, Nagamatsu T, Oda K, Kiyono T, Osuga Y, Fujii T.
    BMC Cancer; 2018 Dec 03; 18(1):1201. PubMed ID: 30509235
    [Abstract] [Full Text] [Related]

  • 15. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
    Obiezu CV, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Rigault de la Longrais IA, Arisio R, Diamandis EP.
    Clin Cancer Res; 2001 Aug 03; 7(8):2380-6. PubMed ID: 11489816
    [Abstract] [Full Text] [Related]

  • 16. p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation.
    Ip CK, Yung S, Chan TM, Tsao SW, Wong AS.
    Oncotarget; 2014 Oct 15; 5(19):9133-49. PubMed ID: 25193855
    [Abstract] [Full Text] [Related]

  • 17. Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
    He Y, Wu AC, Harrington BS, Davies CM, Wallace SJ, Adams MN, Palmer JS, Roche DK, Hollier BG, Westbrook TF, Hamidi H, Konecny GE, Winterhoff B, Chetty NP, Crandon AJ, Oliveira NB, Shannon CM, Tinker AV, Gilks CB, Coward JI, Lumley JW, Perrin LC, Armes JE, Hooper JD.
    Oncogene; 2016 Jan 28; 35(4):468-78. PubMed ID: 25893298
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
    Chen YX, Wang Y, Fu CC, Diao F, Song LN, Li ZB, Yang R, Lu J.
    Endocr Relat Cancer; 2010 Mar 28; 17(1):39-50. PubMed ID: 19776289
    [Abstract] [Full Text] [Related]

  • 19. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.
    Chen MW, Yang ST, Chien MH, Hua KT, Wu CJ, Hsiao SM, Lin H, Hsiao M, Su JL, Wei LH.
    Cancer Res; 2017 Apr 15; 77(8):1955-1967. PubMed ID: 28209618
    [Abstract] [Full Text] [Related]

  • 20. Ca2+ -activated K+ channel KCa 1.1 as a therapeutic target to overcome chemoresistance in three-dimensional sarcoma spheroid models.
    Ohya S, Kajikuri J, Endo K, Kito H, Elboray EE, Suzuki T.
    Cancer Sci; 2021 Sep 15; 112(9):3769-3783. PubMed ID: 34181803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.